July 29, 2014 5:35 PM ET

Pharmaceuticals

Company Overview of QOL Medical, LLC

Executive Profile

William M. Dupere

Chief Operating Officer, QOL Medical, LLC
AgeTotal Calculated CompensationThis person is connected to 1 Board Members in 1 different organizations across 2 different industries.

See Board Relationships
----

Background

Mr. William M. Dupere has been the Chief Operating Officer of QOL Medical, LLC since 2010. Prior to joining QOL Medical in 2010, Mr. Dupere spent twenty years in a variety of pharmaceutical operational and consulting capacities with companies such as GSK, Eli Lilly, Genentech, Amgen, Sanofi and US Oncology. Mr. Dupere's operational focus was primarily on new product launches through initial commercialization with products such as Gemzar, Herceptin, Rituxan and Eloxatin. ...

Corporate Headquarters

4445 North Highway A1A
Vero Beach, Florida 32963

United States

Phone: 866-469-3773
Fax: 772-365-3375

Board Members Memberships

There is no Board Members Memberships data available.

Education

Bachelor's Degree
University of North Carolina
MBA
University of North Carolina

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact QOL Medical, LLC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.